The Impact of HbA1c Level on the Risk of End Stage Renal Disease in T2DM Patients with or without Hypertension: What is the Therapeutic Target?
- DOI
- 10.9734/jammr/2025/v37i55844
- Published
- 2025-06-02
- Container
- Journal of Advances in Medicine and Medical Research
- Publisher
- Sciencedomain International
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.9734/jammr/2025/v37i55844,
title = {The Impact of HbA1c Level on the Risk of End Stage Renal Disease in T2DM Patients with or without Hypertension: What is the Therapeutic Target?},
author = {Essam Fouly and Greg Byrne},
year = {2025},
journal = {Journal of Advances in Medicine and Medical Research},
doi = {10.9734/jammr/2025/v37i55844},
url = {https://doi.org/10.9734/jammr/2025/v37i55844}
}RIS
TY - JOUR TI - The Impact of HbA1c Level on the Risk of End Stage Renal Disease in T2DM Patients with or without Hypertension: What is the Therapeutic Target? AU - Essam Fouly AU - Greg Byrne PY - 2025 JO - Journal of Advances in Medicine and Medical Research DO - 10.9734/jammr/2025/v37i55844 UR - https://doi.org/10.9734/jammr/2025/v37i55844 ER -
APA
Fouly, E., & Byrne, G. (2025). The Impact of HbA1c Level on the Risk of End Stage Renal Disease in T2DM Patients with or without Hypertension: What is the Therapeutic Target?. Journal of Advances in Medicine and Medical Research. https://doi.org/10.9734/jammr/2025/v37i55844
Source records
- crossref · retrieved 2026-09-26T15:24:18.133Z